Ep Wealth Advisors, LLC Novo Cure LTD Transaction History

Ep Wealth Advisors, LLC

10 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Aug 14, 2023	BUY	$40.29 - $82.51 $3,464 - $7,095	86 Added 1.51%	5,781 $239,000
Q1 2023 Jun 05, 2023	BUY	$56.44 - $118.81 $321,425 - $676,622	5,695 New	5,695 $342,000
Q4 2022 Jun 12, 2023	BUY	$63.98 - $85.37 $48,560 - $64,795	759 Added 13.33%	6,454 $473,000
Q2 2022 Aug 11, 2022	SELL	$56.6 - $89.9 $144,386 - $229,334	-2,551 Closed	0 $0
Q1 2022 May 20, 2022	BUY	$60.15 - $84.52 $153,442 - $215,610	2,551 New	2,551 $211,000
Q4 2021 Feb 17, 2022	SELL	$75.08 - $121.99 $191,829 - $311,684	-2,555 Closed	0 $0
Q3 2021 Nov 23, 2021	SELL	$116.17 - $194.55 $1.39 Million - $2.33 Million	-11,969 Reduced 82.41%	2,555 $297,000
Q3 2021 Nov 16, 2021	BUY	$116.17 - $194.55 $1.48 Million - $2.47 Million	12,708 Added 699.78%	14,524 $297,000
Q2 2021 Aug 24, 2021	BUY	$130.4 - $225.58 $7,041 - $12,181	54 Added 3.06%	1,816 $403,000
Q1 2021 May 17, 2021	BUY	$124.11 - $190.17 $218,681 - $335,079	1,762 New	1,762 $233,000

263

76.9M

1.17M

318K

Ticker NVCR
Exchange NASDAQ
Sector Healthcare
Industry Medical Instruments & Supplies
Shares Outstandng 104,950,000
Market Cap $2.76B
Description
NovoCure Limited, an oncology company, engages in the development, manufacture, and commercialization of tumor treating fields (TTFields) devices for the treatment of solid tumor cancers in the United States, Europe, the Middle East, Africa, Japan, and Greater China. Its TTFields devices include Optune for the treatment of glioblastoma; and Optu...

Get notified when there are updates to the investment portfolio of Ep Wealth Advisors, LLC, based on Form 13F filings with the SEC.

Stay updated on Ep Wealth Advisors, LLC with notifications on news.